Implanted spinal neuromodulation interventions for chronic pain in adults
CONCLUSIONS: We found very low-certainty evidence that SCS may not provide clinically important benefits on pain intensity compared to placebo stimulation. We found low- to very low-certainty evidence that SNMD interventions may provide clinically important benefits for pain intensity when added to conventional medical management or physical therapy. SCS is associated with complications including infection, electrode lead failure/migration and a need for reoperation/re-implantation. The level of certainty regarding the size of those risks is very low. SNMD may lead to serious adverse events, including death. We found no evidence to support or refute the use of DRGS for chronic pain.PMID:34854473 | DOI:10.1002/14651858.CD013756.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Neil E O'Connell Michael C Ferraro William Gibson Andrew Sc Rice Lene Vase Doug Coyle Christopher Eccleston Source Type: research
More News: Back Pain | Brain | Cancer | Cancer & Oncology | Chronic Pain | Clinical Trials | Databases & Libraries | Disability | Ganglions | General Medicine | Healthcare Costs | International Medicine & Public Health | Neurology | Neuroscience | Pain | Pain Management | Physical Therapy | Science | Skin | Study | WHO